UShare Medical, a subsidiary of Honest Group, in collaboration with Jinan University, has developed Hyalsome?, a groundbreaking hyaluronic acid liposome technology. By integrating large hyaluronic acid molecules into the liposome shell, this innovation enhances transdermal absorption, boosts efficacy, and improves encapsulation stability. Expanding beyond traditional liposome technology, Hyalsome? ensures higher performance and superior skincare benefits for various applications. With a comprehensive R&D framework, UShare Medical offers customized active ingredient encapsulation services, covering: new carrier and encapsulation research, formula development and efficacy validation, process R&D, production conversion, and quality control.